Locations

Stockholm, Sweden · Misgav, Israel · Qiryat Shemona, Israel

industry

Pharmaceuticals

Size

1 - 10 employees

Stage

Other

founded in

1979

MigVax is a startup developing MIGVAX-101, a novel oral subunit COVID-19 vaccine that has demonstrated effectiveness in pre-clinical tests as a booster for previously vaccinated persons.


Is this your company?

If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the Israel VC Forum network.

Something looks off?
Open jobs at MigVax

On-site & Remote